|
|
|
Volumn 25, Issue 5 SUPPL. 12, 1998, Pages 3-6
|
|
Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: A literature survey
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
PACLITAXEL;
ADVANCED CANCER;
ARTICLE;
BLOOD TOXICITY;
BREAST CANCER;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DRUG EFFICACY;
DRUG SAFETY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DOXORUBICIN;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
|
|
EID: 0031775149
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (32)
|
